02 September, 2026 | Wednesday | News

 Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreement with the U.S. government that reflects our commitment...

04 September, 2026 | Friday | News

Dedicated absorbance reader helps academic, biotech, pharmaceutical and quality control labs generate reliable data for common biological assays with straightforward operation Thermo Fisher Scientific announce...

03 September, 2026 | Thursday | News

Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400 institutions across 33 countries ordering DNA construc...

01 September, 2026 | Tuesday | News

WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announces the distribution of its 2026 interim cas...

04 September, 2026 | Friday | Analysis

A gerotherapeutic that delays five diseases by three years each would produce savings across five budget lines over thirty years, and a cost that lands in one budget line immediately. Read against their own pub...

03 September, 2026 | Thursday | News

Following U.S. FDA 510(k) clearance and Japanese regulatory approval, Photonova Spectra has also achieved CE Mark, supporting expanded research and clinical adoption across Europe and other global markets Po...

04 September, 2026 | Friday | News

Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the expansion...